Israel Self-injections Market to 2032
Overview
The Israel Self-injections Market is expected to reach a 440.96 USD Million by 2032 and is projected to grow at a CAGR of 8.82% from 2025 to 2032.
Revenue, 2024 (USD Million)
244.02
Forecast, 2032 (USD Million)
440.96
CAGR, 2024 - 2032
8.82%
Report Coverage
Israel
Israel Self-injections Market 2018-2032 USD Million
Israel Self-injections Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 244.02 USD Million
- Projected Market Size (2032): 440.96 USD Million
- CAGR (2025-2032): 8.82%
Key Findings of Israel Self-injections Market
- The Israel Self-injections Market was valued at 244.02 USD Million in 2024.
- The Israel Self-injections Market is likely to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Subcutaneous in Route of Administration Segment accounted for the largest share of the market with a revenue of 213.17 USD Million
- The fastest growing segment Autoimmune Diseases in Application Segment grew Fastest with a CAGR of 9.51% during the forecast period from 2024 to 2032.
Israel Self-injections Market Scope
Israel Self-injections Market Segmentation & Scope
Route of Administration
- Others
- Intra muscular
- Subcutaneous
Dosage Form
- Multi-Dose
- Single Dose
Application
- Others
- Hormonal Disorders
- Oncology
- Emergency Drugs
- Pain Management
- Autoimmune Diseases
Product Type
- Self-Injection Formulation
- Self-Injection Devices
Age Group
- Pediatric
- Geriatric
- Adult
Distribution Channel
- Others
- Online Pharmacy
- Hospital Pharmacy
- Direct Tender
Gender
- Female
- Male
Israel Self-injections Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 244.02 USD Million |
| Market Value in 2032 | 440.96 USD Million |
| CAGR (2025-2032) | 8.82% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Route of Administration,Dosage Form,Application,Product Type,Age Group,Distribution Channel,Gender |
Regional Insights:
-
Leading Market (2024-2032): Israel, leading in terms of revenue 244.02 USD Million in 2024
- Key Country: Israel, leading in terms of revenue with value of 244.02 USD Million in 2024.
Segments and Scope
-
Israel Self-injections Market to 2032, By Route of Administration
- Subcutaneous is the largest segment in Israel Self-injections Market to 2032 with a revenue of 213.17 USD Million in the year 2024.
- Subcutaneous is the Fastest growing segment in Israel Self-injections Market to 2032 with a Growth rate of 8.87 % in forecast period 2025-2032.
-
Israel Self-injections Market to 2032, By Dosage Form
- Single Dose is the largest segment in Israel Self-injections Market to 2032 with a revenue of 165.80 USD Million in the year 2024.
- Single Dose is the Fastest growing segment in Israel Self-injections Market to 2032 with a Growth rate of 9.02 % in forecast period 2025-2032.
-
Israel Self-injections Market to 2032, By Application
- Autoimmune Diseases is the largest segment in Israel Self-injections Market to 2032 with a revenue of 109.15 USD Million in the year 2024.
- Autoimmune Diseases is the Fastest growing segment in Israel Self-injections Market to 2032 with a Growth rate of 9.51 % in forecast period 2025-2032.
-
Israel Self-injections Market to 2032, By Product Type
- Self-Injection Devices is the largest segment in Israel Self-injections Market to 2032 with a revenue of 174.04 USD Million in the year 2024.
- Self-Injection Formulation is the Fastest growing segment in Israel Self-injections Market to 2032 with a Growth rate of 8.68 % in forecast period 2025-2032.
-
Israel Self-injections Market to 2032, By Age Group
- Adult is the largest segment in Israel Self-injections Market to 2032 with a revenue of 124.09 USD Million in the year 2024.
- Adult is the Fastest growing segment in Israel Self-injections Market to 2032 with a Growth rate of 9.14 % in forecast period 2025-2032.
-
Israel Self-injections Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Israel Self-injections Market to 2032 with a revenue of 141.36 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Israel Self-injections Market to 2032 with a Growth rate of 9.17 % in forecast period 2025-2032.
-
Israel Self-injections Market to 2032, By Gender
- Male is the largest segment in Israel Self-injections Market to 2032 with a revenue of 155.63 USD Million in the year 2024.
- Male is the Fastest growing segment in Israel Self-injections Market to 2032 with a Growth rate of 8.97 % in forecast period 2025-2032.
Israel Self-injections Market Company Share Analysis
| Company Name |
|
||
| Novo Nordisk A/S | |||
| Sanofi | |||
| AbbVie Inc. | |||
| Amgen Inc. | |||
| Johnson & Johnson Private Limited | |||
Israel Self-injections Market Geographical Sales Distribution, 2018-2032 USD Million
Israel Self-injections Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Israel Self-injections Market is segmented based on Segmentation Route of Administration,Dosage Form,Application,Product Type,Age Group,Distribution Channel,Gender.
Israel Self-injections Market was valued at USD 244.02(Revenue in USD Million) in 2023.
Israel Self-injections Market is projected to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
The Subcutaneous segment is expected to dominate the Israel Self-injections Market, holding a largest market share of 213.17 USD Million in 2024
Israel Self-injections Market Scope
Israel Self-injections Market Segmentation & Scope
Route of Administration
- Others
- Intra muscular
- Subcutaneous
Dosage Form
- Multi-Dose
- Single Dose
Application
- Others
- Hormonal Disorders
- Oncology
- Emergency Drugs
- Pain Management
- Autoimmune Diseases
Product Type
- Self-Injection Formulation
- Self-Injection Devices
Age Group
- Pediatric
- Geriatric
- Adult
Distribution Channel
- Others
- Online Pharmacy
- Hospital Pharmacy
- Direct Tender
Gender
- Female
- Male
Frequently Asked Questions
The Israel Self-injections Market is segmented based on Segmentation Route of Administration,Dosage Form,Application,Product Type,Age Group,Distribution Channel,Gender.
Israel Self-injections Market was valued at USD 244.02(Revenue in USD Million) in 2023.
Israel Self-injections Market is projected to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Self-injections Market for final year is USD 440.96 (USD Million).
Israel Self-injections Market Company Profiling
Frequently Asked Questions
The Israel Self-injections Market is segmented based on Segmentation Route of Administration,Dosage Form,Application,Product Type,Age Group,Distribution Channel,Gender.
Israel Self-injections Market was valued at USD 244.02(Revenue in USD Million) in 2023.
Israel Self-injections Market is projected to grow at a CAGR of 8.82% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Self-injections Market for final year is USD 440.96 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.